PeopleBio's Mission Statement
PeopleBio provides pathfinding bio-products that inspire the diagnosis and treatment for
neurodegenerative diseases through unconventional thinking and innovative work place.
Founded in 2002, PeopleBio is a biotech company specialized in developing diagnostics for
protein misfolding diseases with its proprietary technology, Multimer Detection System (MDS).
Our technical advance in the development of tests for the early detection of protein-based diseases
is recognized by global R&D networks and has established research cooperation with
governmental health organizations, universities and pharmaceutical companies over the world.
Early detection of neurodegenerative diseases is critical, the disease pathology is known to
begin more than a decade prior to the onset of related symptoms.
Early detection of causative proteins would allow people to access available treatments
and be the key to the development of disease modifying drugs.
PeopleBio aims to become an innovative solution provider for the early diagnosis of protein misfolding diseases especially,
neurodegenerative diseases to contribute to improved quality of life for patients and lower burden for society.